相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunological mechanisms of the antitumor effects of supplemental oxygenation
Stephen M. Hatfield et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Mechanisms of Hypoxia-Mediated Immune Escape in Cancer
Ivraym B. Barsoum et al.
CANCER RESEARCH (2014)
ROS Function in Redox Signaling and Oxidative Stress
Michael Schieber et al.
CURRENT BIOLOGY (2014)
Regulation of MHC Class I Expression by Foxp3 and Its Effect on Regulatory T Cell Function
Jie Mu et al.
JOURNAL OF IMMUNOLOGY (2014)
Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection
Stephen M. Hatfield et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges
Pramod K. Srivastava et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression
Beatrice Philip et al.
CARCINOGENESIS (2013)
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Gregg L. Semenza
JOURNAL OF CLINICAL INVESTIGATION (2013)
Major Histocompatibility Complex Class I Core Promoter Elements Are Not Essential for Transcription In Vivo
Zohar S. Barbash et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
The VHL/HIF axis in clear cell renal carcinoma
Chuan Shen et al.
SEMINARS IN CANCER BIOLOGY (2013)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
MECHANISMS OF DISEASE Purinergic Signaling during Inflammation
Holger K. Eltzschig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The determinants of tumour immunogenicity
Thomas Blankenstein et al.
NATURE REVIEWS CANCER (2012)
Immunotherapy eradicates metastases with reversible defects in MHC class I expression
Cristina Garrido et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires
Claudia C. Oliveira et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma
A. Perier et al.
ONCOGENE (2011)
In vivo T cell activation in lymphoid tissues is inhibited in the oxygen-poor microenvironment
Akio Ohta et al.
FRONTIERS IN IMMUNOLOGY (2011)
Expression regulation of major histocompatibility complex class I and class II encoding genes
Peter J. van den Elsen
FRONTIERS IN IMMUNOLOGY (2011)
Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
David R. Mole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations
Natalia Aptsiauri et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: Role of nitric oxide
D. Robert Siemens et al.
CANCER RESEARCH (2008)
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy
Rafael Carretero et al.
IMMUNOGENETICS (2008)
The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer
William G. Kaelin
NATURE REVIEWS CANCER (2008)
ROS as signalling molecules:: mechanisms that generate specificity in ROS homeostasis
Benoit D'Autreaux et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13
S. V. Ivanov et al.
ONCOGENE (2007)
Renal cancer cells lacking hypoxia inducible factor (HIF)-1 alpha expression maintain vascular endothelial growth factor expression through HIF-2 alpha
Toshiaki Shinojima et al.
CARCINOGENESIS (2007)
On the definition of a criterion of immunogenicity
Thomas Pradeu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Eric A. Reits et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Defects in the human leukocyte antigen class I antigen-processing machinery in head and neck squamous cell carcinoma: Association with clinical outcome
M Meissner et al.
CLINICAL CANCER RESEARCH (2005)
Transcriptional regulation of antigen presentation
PJ van den Elsen et al.
CURRENT OPINION IN IMMUNOLOGY (2004)
The von Hippel-Lindau tumor suppressor gene and kidney cancer
WG Kaelin
CLINICAL CANCER RESEARCH (2004)
The hypoxic tumor microenvironment and gene expression
C Leo et al.
SEMINARS IN RADIATION ONCOLOGY (2004)
Distinct transcriptional pathways regulate basal and activate major histocompatibility complex class I expression
TK Howcroft et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Interferon regulatory factor-1 is required for interferon-gamma-induced MHC class I genes in astrocytes
KW Jarosinski et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide
P Cascio et al.
EMBO JOURNAL (2001)
MHC class I antigen processing of an Adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells
AJAM Sijts et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
